KCTV: Atrial Fibrillation and New Treatment
Atrial fibrillation, or a-fib, is the most common type of treated heart arrhythmia, and it is estimated that 12.1 million people in the United States will have a-fib in 2030. Untreated, a-fib significantly increases your risk of heart attack and stroke, yet many people with a-fib have never been diagnosed.
Dr. Sanjaya Gupta, electrophysiologist at Saint Luke's Mid America Heart Institute, talks with KCTV about risk factors and new treatment available at Saint Luke's Atrial Fibrillation Clinic.
Recent News
News
Media Coverage: Doctor Weighs In on Patrick Mahomes’ ACL Recovery After Chiefs Confirm Injury
News
KMBC: Santa Surprises Saint Luke’s NICU Families With Special Holiday Visit
News
Media Coverage: Grandfather Grateful To Be Alive After Grandson’s Quick Thinking Saved His Life
Patient Stories
Roadside Heroics Lead One Grandfather to Lifesaving Care at Saint Luke’s Mid America Heart Institute
Patient Stories
A Team Effort Brings Patient Back to Life at Saint Luke’s Mid America Heart Institute
News